Melexis NV (MELE) - Net Assets
Based on the latest financial reports, Melexis NV (MELE) has net assets worth €484.53 Million EUR (≈ $566.47 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€903.27 Million ≈ $1.06 Billion USD) and total liabilities (€418.74 Million ≈ $489.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Melexis NV liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €484.53 Million |
| % of Total Assets | 53.64% |
| Annual Growth Rate | 7.76% |
| 5-Year Change | 24.54% |
| 10-Year Change | 84.61% |
| Growth Volatility | 18.61 |
Melexis NV - Net Assets Trend (2002–2025)
This chart illustrates how Melexis NV's net assets have evolved over time, based on quarterly financial data. Also explore Melexis NV (MELE) total assets for the complete picture of this company's asset base.
Annual Net Assets for Melexis NV (2002–2025)
The table below shows the annual net assets of Melexis NV from 2002 to 2025. For live valuation and market cap data, see MELE stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €484.53 Million ≈ $566.47 Million |
-14.62% |
| 2024-12-31 | €567.50 Million ≈ $663.47 Million |
+2.98% |
| 2023-12-31 | €551.07 Million ≈ $644.26 Million |
+14.31% |
| 2022-12-31 | €482.08 Million ≈ $563.61 Million |
+23.91% |
| 2021-12-31 | €389.06 Million ≈ $454.85 Million |
+23.60% |
| 2020-12-31 | €314.78 Million ≈ $368.01 Million |
+5.25% |
| 2019-12-31 | €299.07 Million ≈ $349.64 Million |
-8.26% |
| 2018-12-31 | €326.01 Million ≈ $381.14 Million |
+10.77% |
| 2017-12-31 | €294.30 Million ≈ $344.07 Million |
+12.13% |
| 2016-12-31 | €262.46 Million ≈ $306.85 Million |
+8.23% |
| 2015-12-31 | €242.51 Million ≈ $283.52 Million |
+20.44% |
| 2014-12-31 | €201.36 Million ≈ $235.41 Million |
+27.74% |
| 2013-12-31 | €157.64 Million ≈ $184.30 Million |
+21.94% |
| 2012-12-31 | €129.28 Million ≈ $151.14 Million |
+20.68% |
| 2011-12-31 | €107.12 Million ≈ $125.24 Million |
+12.22% |
| 2010-12-31 | €95.46 Million ≈ $111.60 Million |
+59.48% |
| 2009-12-31 | €59.85 Million ≈ $69.98 Million |
-2.72% |
| 2008-12-31 | €61.53 Million ≈ $71.93 Million |
-21.27% |
| 2007-12-31 | €78.15 Million ≈ $91.36 Million |
+12.26% |
| 2006-12-31 | €69.61 Million ≈ $81.39 Million |
+12.68% |
| 2005-12-31 | €61.78 Million ≈ $72.23 Million |
+12.59% |
| 2004-12-31 | €54.87 Million ≈ $64.15 Million |
-36.31% |
| 2003-12-31 | €86.15 Million ≈ $100.72 Million |
-0.82% |
| 2002-12-31 | €86.87 Million ≈ $101.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Melexis NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 806.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €539.61 Million | 111.37% |
| Common Stock | €565.00K | 0.12% |
| Other Comprehensive Income | €-5.61 Million | -1.16% |
| Total Equity | €484.53 Million | 100.00% |
Melexis NV Competitors by Market Cap
The table below lists competitors of Melexis NV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
JHT Design Co. Ltd. Cl A
SHG:603061
|
$2.24 Billion |
|
PACS Group, Inc.
NYSE:PACS
|
$2.24 Billion |
|
Suzhou K-Hiragawa Electronic Technology Co. Ltd. A
SHG:603052
|
$2.24 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
$2.24 Billion |
|
Visual China Group Co Ltd
SHE:000681
|
$2.24 Billion |
|
Valiant Co Ltd
SHE:002643
|
$2.24 Billion |
|
Gansu Qilianshan Cement Group Co Ltd
SHG:600720
|
$2.24 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
$2.24 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Melexis NV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 567,501,000 to 484,529,000, a change of -82,972,000 (-14.6%).
- Net income of 112,505,000 contributed positively to equity growth.
- Dividend payments of 147,851,000 reduced retained earnings.
- Share repurchases of 45,621,000 reduced equity.
- Other comprehensive income decreased equity by 2,352,131.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €112.50 Million | +23.22% |
| Dividends Paid | €147.85 Million | -30.51% |
| Share Repurchases | €45.62 Million | -9.42% |
| Other Comprehensive Income | €-2.35 Million | -0.49% |
| Other Changes | €347.13K | +0.07% |
| Total Change | €- | -14.62% |
Book Value vs Market Value Analysis
This analysis compares Melexis NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.91x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 37.45x to 5.91x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €1.90 | €71.35 | x |
| 2003-12-31 | €1.89 | €71.35 | x |
| 2004-12-31 | €1.23 | €71.35 | x |
| 2005-12-31 | €1.43 | €71.35 | x |
| 2006-12-31 | €1.61 | €71.35 | x |
| 2007-12-31 | €1.81 | €71.35 | x |
| 2008-12-31 | €1.42 | €71.35 | x |
| 2009-12-31 | €1.38 | €71.35 | x |
| 2010-12-31 | €2.21 | €71.35 | x |
| 2011-12-31 | €2.48 | €71.35 | x |
| 2012-12-31 | €3.13 | €71.35 | x |
| 2013-12-31 | €3.90 | €71.35 | x |
| 2014-12-31 | €4.98 | €71.35 | x |
| 2015-12-31 | €6.00 | €71.35 | x |
| 2016-12-31 | €6.50 | €71.35 | x |
| 2017-12-31 | €7.28 | €71.35 | x |
| 2018-12-31 | €8.07 | €71.35 | x |
| 2019-12-31 | €7.47 | €71.35 | x |
| 2020-12-31 | €7.86 | €71.35 | x |
| 2021-12-31 | €9.63 | €71.35 | x |
| 2022-12-31 | €11.93 | €71.35 | x |
| 2023-12-31 | €13.64 | €71.35 | x |
| 2024-12-31 | €14.03 | €71.35 | x |
| 2025-12-31 | €12.08 | €71.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Melexis NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.40%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 1.86x
- Recent ROE (23.22%) is below the historical average (35.04%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 24.91% | 18.31% | 1.05x | 1.30x | €12.95 Million |
| 2003 | 28.53% | 18.40% | 1.10x | 1.41x | €15.96 Million |
| 2004 | 45.34% | 16.72% | 1.21x | 2.24x | €19.39 Million |
| 2005 | 45.58% | 16.21% | 1.46x | 1.93x | €21.98 Million |
| 2006 | 49.60% | 17.13% | 1.19x | 2.44x | €27.57 Million |
| 2007 | 47.45% | 18.17% | 1.21x | 2.16x | €29.27 Million |
| 2008 | 36.49% | 12.10% | 1.18x | 2.56x | €16.30 Million |
| 2009 | -6.67% | -3.09% | 0.84x | 2.58x | €-9.97 Million |
| 2010 | 50.93% | 22.15% | 1.22x | 1.89x | €39.07 Million |
| 2011 | 42.85% | 19.90% | 1.30x | 1.66x | €35.18 Million |
| 2012 | 39.86% | 20.86% | 1.26x | 1.51x | €38.60 Million |
| 2013 | 35.03% | 20.05% | 1.28x | 1.36x | €39.45 Million |
| 2014 | 42.21% | 25.57% | 1.29x | 1.28x | €64.86 Million |
| 2015 | 40.85% | 24.76% | 1.30x | 1.27x | €74.82 Million |
| 2016 | 36.68% | 21.10% | 1.27x | 1.36x | €70.01 Million |
| 2017 | 37.70% | 21.69% | 1.27x | 1.37x | €81.53 Million |
| 2018 | 35.41% | 20.28% | 1.33x | 1.31x | €82.85 Million |
| 2019 | 20.15% | 12.38% | 1.16x | 1.40x | €30.35 Million |
| 2020 | 22.02% | 13.65% | 1.17x | 1.38x | €37.82 Million |
| 2021 | 33.70% | 20.37% | 1.40x | 1.19x | €92.20 Million |
| 2022 | 40.90% | 23.58% | 1.44x | 1.20x | €148.94 Million |
| 2023 | 38.01% | 21.72% | 1.11x | 1.57x | €154.36 Million |
| 2024 | 30.21% | 18.38% | 1.04x | 1.58x | €114.70 Million |
| 2025 | 23.22% | 13.40% | 0.93x | 1.86x | €64.05 Million |
Industry Comparison
This section compares Melexis NV's net assets metrics with peer companies in the Semiconductors industry.
No peer company data available for comparison.
About Melexis NV
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America. It offers current, inductive position, latch and switch, magnetic position, speed, optical, pressure, temperature, and tire monitoring sensors ICs, as well as time-of-flight ICs; embedded… Read more